EuBiologics Co., Ltd. (KOSDAQ: A206650)
Health Care · Biotechnology · KR
₩8,420.00
-0.36% today · -34.7% 1Y
EuBiologics Co., Ltd. (KOSDAQ: A206650) operates in the Biotechnology industry within the Health Care sector. The company is valued at $230.18M.
Over the last twelve months the share price has lost 34.7%, trading between 6.95K and 17.70K.
Tweenvest scores EuBiologics Co., Ltd. across four factors: quality 87/100, value 54/100. Its strongest factor is quality.
A206650 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $230.18M
- Revenue (TTM)
- $65.01M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.32
- 52-week high
- ₩17,700.00
- 52-week low
- ₩6,950.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.75M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| InflaRx N.V.NasdaqGS: IFRX | $235.79M | $1.60 | +4.58% |
| Tetratherix LimitedASX: TTX | $234.75M | AU$6.34 | -1.71% |
| PegBio Co., Ltd.SEHK: 2565 | $233.73M | HK$4.69 | -3.10% |
| Alector, Inc.NasdaqGS: ALEC | $232.25M | $2.08 | +2.97% |
| ProQR Therapeutics N.V.NasdaqCM: PRQR | $230.03M | $1.63 | -0.31% |
| Valerio Therapeutics Société anonymeENXTPA: ALVIO | $229.28M | €0.41 | +7.61% |
| Spectral Medical Inc.TSX: EDT | $228.66M | CA$1.11 | -5.53% |
| Evommune, Inc.NYSE: EVMN | $226.83M | $6.25 | -2.50% |
Figures last refreshed Oct 11, 2026.